Clinical Trials Directory

Trials / Completed

CompletedNCT01354327

Effects of Limicol on LDL-cholesterol

Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Lescuyer Laboratory · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLimicol3 tablets / day during 4 months
DIETARY_SUPPLEMENTPlacebo3 tablets / day during 4 months

Timeline

Start date
2008-12-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2011-05-16
Last updated
2011-05-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01354327. Inclusion in this directory is not an endorsement.

Effects of Limicol on LDL-cholesterol (NCT01354327) · Clinical Trials Directory